hp828-101
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2010 (NCT01135290)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hp-828-101
- hp828-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01273428 | Phase 2 | Dec 3, 2010 | Healthpoint |
| NCT01135290 | Early Phase 1 (Phase 1) | Jun 1, 2010 | Healthpoint, The University of Texas, Dallas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Healthpoint | For profit | 2 | 2 | 2 | 2010 |
| The University of Texas, Dallas | Academic/Hospital | 1 | 0 | 1 | 2010 |
2 organizations
Page 1 / 1